| Financial Year |
March 31 2023 |
| Monetary Funds |
53,370,165,552.97 |
| Held-for-trading Financial Assets |
10,095,107,575.21 |
| Notes Receivable |
3,067,611,537.70 |
| Accounts Receivable |
107,885,815,445.03 |
| Advances to Suppliers |
22,548,483,368.01 |
| Other Receivables |
78,962,862,655.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,050,767.58 |
| Dividend Receivable |
417,802,839.93 |
| Inventories |
651,621,710,819.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,303,412,093.53 |
| Other Current Assets |
33,301,232,852.93 |
| Total Current Assets |
1,135,222,406,468.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,223,489,241.62 |
| Long-term Equity Investment |
40,634,125,808.20 |
| Investment Properties |
21,468,417,963.49 |
| Fixed Assetes |
50,677,592,194.36 |
| Under-construction Projects |
3,567,983,220.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
15,384,932.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,838,234,949.39 |
| R&D expenses |
2,307,396.18 |
| Goodwill |
3,399,581,600.47 |
| Long-Term Deferred and Prepaid Expenses |
642,946,318.60 |
| Deferred Income Tax Assets |
21,005,266,635.39 |
| Other Non-Current Assets |
12,584,413,732.93 |
| Sub-Total of Non-Current Assets |
200,934,305,531.74 |
| Total Assets |
1,336,156,711,999.84 |
| Short-Term Loans |
29,156,952,974.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,839,197,574.55 |
| Accounts Payable |
390,147,366,058.79 |
| Accounts Received In Advance |
1,405,192,920.47 |
| Employee Compensation Payable |
1,612,671,039.50 |
| Taxes Payable |
46,135,436,328.82 |
| Interest Payable |
-- |
| Dividend Payable |
1,506,123,523.81 |
| Other payables |
58,720,121,265.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,209,352,729.65 |
| Other Current Liabilities |
44,627,960,773.18 |
| Sub-Total of Current Liabilities |
1,048,008,653,834.61 |
| Long-term Loans |
67,584,406,156.43 |
| Bonds Payable |
25,726,811,994.43 |
| Long-Term Accounts Payable |
11,320,768,828.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
771,063,175.16 |
| Deferred Income Tax Liabilities |
2,898,747,116.03 |
| Other Non-Current Liabilities |
6,580,460,677.06 |
| Sub-Total of Non-Current Liabilities |
121,924,325,546.06 |
| Total Liabilities |
1,169,932,979,380.67 |
| Paid-In Capital(Or Share Stock) |
14,054,218,314.00 |
| Capital Surplus |
9,956,676,414.11 |
| Surplus Reserve |
6,782,152,925.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
62,779,028,994.95 |
| Minority Stockholder's Interest |
73,374,123,836.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
92,849,608,782.34 |
| Owner's Equity（Stockholder's Equity） |
166,223,732,619.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,336,156,711,999.84 |
